WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of $2.60 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-24.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2020-04-24
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2020-03-31 was $2.60M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2019-12-31 was -$2.10M, a 261.54% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2019-09-30 was $3.20M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2019-06-30 was $1.80M, a 157.14% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2019 was -$400.00K, a 110.53% decline from fiscal 2018.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2018 was $3.80M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2017 was -$1.00M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2016 was -$100.00K, a 108.33% decline from fiscal 2015.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month |
|---|---|---|---|---|
| 2020-03-31 | $2.60M 10-Q · filed 2020-04-24 | $500.00K derived: sum of 2 quarters · filed 2020-04-24 | $3.70M derived: sum of 3 quarters · filed 2020-04-24 | $5.50M derived: sum of 4 quarters · filed 2020-04-24 |
| 2019-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.10M derived: sum of 2 quarters · filed 2020-02-24 | $2.90M derived: sum of 3 quarters · filed 2020-02-24 | -$400.00K 10-K · filed 2020-02-24 |
| 2019-09-30 | $3.20M 10-Q · filed 2019-10-29 | $5.00M derived: sum of 2 quarters · filed 2019-10-29 | $1.70M 10-Q · filed 2019-10-29 | $3.00M derived: sum of 4 quarters · filed 2020-04-24 |
| 2019-06-30 | $1.80M 10-Q · filed 2019-07-29 | -$1.50M 10-Q · filed 2019-07-29 | -$200.00K derived: sum of 3 quarters · filed 2020-04-24 | -$600.00K derived: sum of 4 quarters · filed 2020-04-24 |
| 2019-03-31 | -$3.30M 10-Q · filed 2020-04-24 | -$2.00M derived: sum of 2 quarters · filed 2020-04-24 | -$2.40M derived: sum of 3 quarters · filed 2020-04-24 | -$1.70M derived: sum of 4 quarters · filed 2020-04-24 |
| 2018-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $900.00K derived: sum of 2 quarters · filed 2020-02-24 | $1.60M derived: sum of 3 quarters · filed 2020-02-24 | $3.80M 10-K · filed 2020-02-24 |
| 2018-09-30 | -$400.00K 10-Q · filed 2019-10-29 | $300.00K derived: sum of 2 quarters · filed 2019-10-29 | $2.50M 10-Q · filed 2019-10-29 | $3.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $700.00K 10-Q · filed 2019-07-29 | $2.90M 10-Q · filed 2019-07-29 | $3.70M derived: sum of 3 quarters · filed 2020-02-24 | $3.10M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $2.20M 10-Q · filed 2019-05-08 | $3.00M derived: sum of 2 quarters · filed 2020-02-24 | $2.40M derived: sum of 3 quarters · filed 2020-02-24 | -$500.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $200.00K derived: sum of 2 quarters · filed 2020-02-24 | -$2.70M derived: sum of 3 quarters · filed 2020-02-24 | -$1.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | -$600.00K 10-Q · filed 2018-10-30 | -$3.50M derived: sum of 2 quarters · filed 2018-10-30 | -$1.80M 10-Q · filed 2018-10-30 | -$2.60M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$2.90M 10-Q · filed 2018-07-31 | -$1.20M 10-Q · filed 2018-07-31 | -$2.00M derived: sum of 3 quarters · filed 2019-02-28 | -$2.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $1.70M 10-Q · filed 2018-05-08 | $900.00K derived: sum of 2 quarters · filed 2019-02-28 | $900.00K derived: sum of 3 quarters · filed 2019-02-28 | $2.30M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$800.00K derived: sum of 2 quarters · filed 2019-02-28 | $600.00K derived: sum of 3 quarters · filed 2019-02-28 | -$100.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2017-10-31 | $1.40M derived: sum of 2 quarters · filed 2017-10-31 | $700.00K 10-Q · filed 2017-10-31 | $400.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $1.40M 10-Q · filed 2017-08-01 | $700.00K 10-Q · filed 2017-08-01 | $400.00K derived: sum of 3 quarters · filed 2018-02-26 | $0.00 derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$700.00K 10-Q · filed 2017-05-05 | -$1.00M derived: sum of 2 quarters · filed 2018-02-26 | -$1.40M derived: sum of 3 quarters · filed 2018-02-26 | -$2.90M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$700.00K derived: sum of 2 quarters · filed 2018-02-26 | -$2.20M derived: sum of 3 quarters · filed 2018-02-26 | $1.20M 10-K · filed 2018-02-26 |
| 2015-09-30 | -$400.00K 10-Q · filed 2016-10-31 | -$1.90M derived: sum of 2 quarters · filed 2016-10-31 | $1.50M 10-Q · filed 2016-10-31 | $1.40M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$1.50M 10-Q · filed 2016-08-01 | $1.90M 10-Q · filed 2016-08-01 | $1.80M derived: sum of 3 quarters · filed 2017-02-28 | $2.90M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $3.40M 10-Q · filed 2016-05-06 | $3.30M derived: sum of 2 quarters · filed 2017-02-28 | $4.40M derived: sum of 3 quarters · filed 2017-02-28 | $4.90M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $1.00M derived: sum of 2 quarters · filed 2017-02-28 | $1.50M derived: sum of 3 quarters · filed 2017-02-28 | $1.70M 10-K · filed 2017-02-28 |
| 2014-09-30 | $1.10M 10-Q · filed 2015-11-02 | $1.60M derived: sum of 2 quarters · filed 2015-11-02 | $1.80M 10-Q · filed 2015-11-02 | $3.40M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $500.00K 10-Q · filed 2015-08-03 | $700.00K 10-Q · filed 2015-08-03 | $2.30M derived: sum of 3 quarters · filed 2016-02-26 | $3.30M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $200.00K 10-Q · filed 2015-05-06 | $1.80M derived: sum of 2 quarters · filed 2016-02-26 | $2.80M derived: sum of 3 quarters · filed 2016-02-26 | $3.50M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.60M derived: sum of 2 quarters · filed 2016-02-26 | $3.30M derived: sum of 3 quarters · filed 2016-02-26 | $3.00M 10-K · filed 2016-02-26 |
| 2013-09-30 | $1.00M 10-Q · filed 2014-11-03 | $1.70M derived: sum of 2 quarters · filed 2014-11-03 | $1.40M 10-Q · filed 2014-11-03 | $400.00K derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $700.00K 10-Q · filed 2014-08-01 | $400.00K 10-Q · filed 2014-08-01 | -$600.00K derived: sum of 3 quarters · filed 2015-02-25 | -$900.00K derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | -$300.00K 10-Q · filed 2014-05-08 | -$1.30M derived: sum of 2 quarters · filed 2015-02-25 | -$1.60M derived: sum of 3 quarters · filed 2015-02-25 | -$4.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$1.30M derived: sum of 2 quarters · filed 2015-02-25 | -$3.70M derived: sum of 3 quarters · filed 2015-02-25 | -$3.60M 10-K · filed 2015-02-25 |
| 2012-09-30 | -$300.00K 10-Q · filed 2013-11-04 | -$2.70M derived: sum of 2 quarters · filed 2013-11-04 | -$2.60M 10-Q · filed 2013-11-04 | -$2.70M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$2.40M 10-Q · filed 2013-08-05 | -$2.40M 10-Q · filed 2013-08-05 | -$2.40M derived: sum of 3 quarters · filed 2014-02-27 | -$2.80M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-06 | $0.00 derived: sum of 2 quarters · filed 2014-02-27 | -$400.00K derived: sum of 3 quarters · filed 2014-02-27 | -$900.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$400.00K derived: sum of 2 quarters · filed 2014-02-27 | -$900.00K derived: sum of 3 quarters · filed 2014-02-27 | -$1.70M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$400.00K 10-Q · filed 2012-11-05 | -$900.00K derived: sum of 2 quarters · filed 2012-11-05 | -$1.70M 10-Q · filed 2012-11-05 | |
| 2011-06-30 | -$500.00K 10-Q · filed 2012-08-06 | -$1.30M 10-Q · filed 2012-08-06 | ||
| 2010-12-31 | -$300.00K 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |